The Ki-67 antigen in primary human melanomas ?its relationship to mitotic rate and tumor thickness and its stability
- 1 June 1989
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 281 (3) , 173-177
- https://doi.org/10.1007/bf00456388
Abstract
We investigated whether two parameters of proliferative activity — mitotic rate and Ki-67 positive cells — are interchangeable. The mitotic rate was assessed on paraffin-embedded sections, Ki-67 positive cells were immunohistologically determined in frozen tissue. A poor correlation (correlation coefficient r=0.57) was found between both parameters. The proliferative activity was often not homogeneously distributed in the tested tumors. However, this is a major reason for the observed difference only in thin melanomas (<1.5 mm) as seen by comparison of tumors with homogeneous and inhomogeneous proliferative activity. We assume that arrest of cells in different stages of the cell cycle — variable from melanoma to melanoma — is the major reason for the observed discrepancy between mitotic rate and Ki-67 positive cells in tumors of 1.5 mm and thicker. The mean number of Ki-67 positive cells increased with tumor thickness. The stability of the Ki-67 antigen towards freezing, thawing, and formalin was studied.This publication has 14 references indexed in Scilit:
- Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cellsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988
- Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.Journal of Clinical Pathology, 1986
- New approach to assessing lung tumours in man.Journal of Clinical Pathology, 1986
- Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determinedin situwith the monoclonal antibody Ki‐67Hematological Oncology, 1984
- Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (?1.5 mm) melanomaArchives of Dermatological Research, 1984
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- Factors Associated with Death from Melanoma from 2 to 5 Years Following Diagnosis in Clinical Stage I PatientsJournal of Investigative Dermatology, 1983
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983
- Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and MetastasisAnnals of Surgery, 1982
- Angewandte StatistikPublished by Springer Nature ,1978